FDA Adverse Event Injury Summary report: N

ENDURANT II STENT GRAFT SYSTEM

MDR report key: 2821638 · Received November 6, 2012

Report

Report Number
2953200-2012-02128
Event Type
Injury
Date Received
November 6, 2012
Date of Event
October 10, 2012
Report Date
October 10, 2012
Manufacturer
MEDTRONIC IRELAND
Product Code
MIH
PMA / PMN Number
P100021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS: INHERENT RISK OF PROCEDURE (ENDOLEAK). PATIENT'S CONDITION AFFECTED EFFECTIVENESS OF DEVICE (ANATOMY RELATED; SEVERELY ANGULATED AORTIC NECK). CONCLUSION: DEVICE FAILURE/LACK OF EFFECTIVENESS RELATED TO PATIENT CONDITION (ANATOMY RELATED; SEVERELY ANGULATED AORTIC NECK).

Description of Event or Problem · 1

AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE EMERGENT ENDOVASCULAR TREATMENT OF A 7.4 CM DIAMETER ABDOMINAL AORTIC ANEURYSM. THE AORTIC NECK WAS 18 MM IN LENGTH AND MEASURED 27 MM IN DIAMETER PROXIMALLY AND 30 MM DISTALLY AND IT WAS SEVERELY ANGULATED WITH MODERATE THROMBUS. THE STENT GRAFT WAS SUCCESSFULLY IMPLANTED AND MODELED THE PROXIMAL AREA OF THE STENT GRAFT WITH A BALLOON SEVERAL TIMES, BUT ON FINAL IMAGING THE PATIENT HAD SMALL PROXIMAL TYPE I ENDOLEAK. THE PATIENT'S CREATININE LEVEL WAS 1.9 BEFORE THE CASE AND THE PHYSICIAN DID NOT WANT TO USE ANYMORE CONTRAST AT THIS TIME. THE PHYSICIAN WILL MONITOR THE PATIENT. NO CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDURANT II STENT GRAFT SYSTEM SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC IRELAND V01696345

Patients

Seq Age Sex Outcome Treatment
1 00076 YR